pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    INCA-033989
    Essential Thrombocythemia$INCY INCYTE CORP
  • Phase 1
    INCB-100658
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)$INCY INCYTE CORP
  • Phase 2
    INKmune
    INKmune
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$INMB Inmune Bio, Inc.
← prev
page 23 of 62
next →
Pain89
Neurology1
Preclinical
INV-441
Glioblastoma Multiforme (GBM)
InvIOs GmbH
  • Preclinical
    INV-724
    Neuroblastoma Invenra Inc
  • Phase 2
    INV-9956
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ionova Life Science Co Ltd
  • Phase 2
    INX-315
    Epithelial Ovarian Cancer Incyclix Bio LLC
  • Phase 1
    IO-202
    Chronic Myelomonocytic Leukemia (CMML) Immune Onc Therapeutics Inc
  • Preclinical
    IO-312
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Immune Onc Therapeutics Inc
  • Phase 2
    IOV-2001
    Chronic Lymphocytic Leukemia (CLL)$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 2
    IOV-4001
    Metastatic Melanoma$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 2
    IPG-7236
    Head And Neck Cancer Immunophage Biotech Co Ltd
  • Phase 1
    IPH-4502
    Breast Cancer$IPHA Innate Pharma SA
  • Phase 1
    ISB-2001
    Refractory Multiple Myeloma$ABBV AbbVie Inc.
  • Phase 1
    ISM-3412
    Solid Tumor InSilico Medicine
  • Phase 1
    ISM-6331
    Malignant Mesothelioma InSilico Medicine
  • Preclinical
    ISM-9274
    Solid Tumor InSilico Medicine
  • Phase 1
    ITI-1001
    Glioblastoma Multiforme (GBM) Immunomic Therapeutics Inc
  • Phase 1
    ITI-3000
    Merkel Cell Carcinoma Immunomic Therapeutics Inc
  • Phase 1
    IVB-003
    Pancreatic Cancer Invictus Therapeutics Ltd
  • Phase 2
    IVS-3001
    Epithelial Ovarian Cancer Invectys SA
  • Preclinical
    IVT-8086
    Osteosarcoma Innova Therapeutics Inc
  • Phase 2
    ImMucin
    ImMucin
    Multiple Myeloma (Kahler Disease) Vaxil Bio Therapeutics Ltd
  • Preclinical
    Immuno-oncology
    Breast Cancer American Gene Technologies International Inc
  • Preclinical
    InfiniTIL
    Unspecified Cancer RootPath Genomics Inc
  • Phase 1
    Innocell Vaccine
    Epithelial Ovarian Cancer PhotonPharma Inc
  • Preclinical
    IrniCann
    (cannabidiol + cannabigerol)
    Glioblastoma Multiforme (GBM) Argent BioPharma Ltd
  • Phase 2
    JAB-23E73
    Metastatic Colorectal Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    JAB-2485
    Small-Cell Lung Cancer Jacobio Pharmaceuticals Group Co Ltd
  • Phase 2
    JAB-30355
    Solid Tumor Jacobio Pharmaceuticals Group Co Ltd